Strategic Planning Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Strategic Planning Group's LLY Position: Q3 2026 in Review
Strategic Planning Group increased its Eli Lilly (LLY) stake by 34% in Q3 2026, buying an estimated $10.2M and bringing the position to 34,284 shares worth $39.7M. The position accounts for 4.11% of the portfolio, ranked #5.
Strategic Planning Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,633 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Strategic Planning Group held 34,284 shares of Eli Lilly worth $39.7M as of Q3 2026.
- Strategic Planning Group bought 8,665 Eli Lilly shares in Q3 2026, an estimated $10.2M.
- Eli Lilly made up 4.11% of Strategic Planning Group's portfolio in Q3 2026, its #5 holding.
- Strategic Planning Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 1,633 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Strategic Planning Group's 13F filing for Q3 2026, filed 22 Oct 2026.